Ambrosia Biosciences
Boulder, Colorado, United States · Biotechnology · 50 employees
Ambrosia Biosciences Inc. is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
Funding history
- Series series b — $100.0M — Mar 2026
- Funding Round — $16.0M — Aug 2024
- Funding Round — $16.0M — Aug 2024
Recent signals
- Mar 31, 2026: Raised $100.0M in Series series b
- Aug 20, 2024: Raised $16.0M
- Aug 07, 2024: Raised $16.0M
See plans & pricing → Track Ambrosia Biosciences’s funding, hiring, and signals — with verified contacts — on Fundz.